Bill
Bill > SB911
MD SB911
MD SB911Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling
summary
Introduced
02/02/2024
02/02/2024
In Committee
02/02/2024
02/02/2024
Crossed Over
Passed
Dead
04/08/2024
04/08/2024
Introduced Session
2024 Regular Session
Bill Summary
Prohibiting a person from offering for sale in the State a gene structure- or function-modifying product unless the product is labeled in a prominent and conspicuous manner with the words "Gene structure- or function-modifying product" and all potential risks, side effects, adverse effects, and other reasonably possible effects that the product may have; and establishing penalties for a violation of the Act.
AI Summary
This bill prohibits the sale of any "gene structure- or function-modifying product" in the state of Maryland unless the product is prominently and conspicuously labeled with the words "Gene structure- or function-modifying product" and all potential risks, side effects, adverse effects, and other reasonably possible effects that the product may have on the individual using it or those who may come into contact with the user. The bill defines "gene structure- or function-modifying product" as a product produced using modern biotechnology methods, such as gene editing, RNA interference, and transgenesis, that alters the structure or function of one or more genes. Violations of the labeling requirement can result in criminal penalties, civil penalties, and injunctions. The bill is intended to provide consumers with information about the genetic modifications in these products.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
Senate Finance Hearing (13:00:00 3/7/2024 ) (on 03/07/2024)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0911?ys=2024RS |
| BillText | https://mgaleg.maryland.gov/2024RS/bills/sb/sb0911f.pdf |
Loading...